Baidu
map

肿瘤科

订阅

MedSci主页 / 所有栏目 / 肿瘤科

晚期卵巢透明细胞癌姑息性化疗无明显获益

2011-08-03 MedSci原创 MedSci原创

卵巢透明细胞癌化疗
关注

来源：医学论坛网 　　加拿大一项研究表明，大多数晚期或复发性肾透明细胞癌（CCC）接受姑息性化疗的获益较少，目前应探索放疗和靶向治疗在这类患者中的应用价值，以改善临床转归。研究论文近期发表于《妇科肿瘤学》（Gynecologic Oncology）杂志。 　　该研究共纳入了158例单纯CCC患者，其中33例晚期患者接受了一线治疗，接受二和三线治疗的患者分别有47和25例。所有患者共接

来源：医学论坛网

　　加拿大一项研究表明，大多数晚期或复发性肾透明细胞癌（CCC）接受姑息性化疗的获益较少，目前应探索放疗和靶向治疗在这类患者中的应用价值，以改善临床转归。研究论文近期发表于《妇科肿瘤学》（Gynecologic Oncology）杂志。

　　该研究共纳入了158例单纯CCC患者，其中33例晚期患者接受了一线治疗，接受二和三线治疗的患者分别有47和25例。所有患者共接受了105个疗程的治疗：单独化疗88个疗程、单独放疗14个疗程和联合治疗3个疗程。获益于化疗、放疗和联合治疗的患者比例分别为24％、64％和100%。无任何一类化疗药被证明有明显疗效。

相关链接：Exploring palliative treatment outcomes in women with advanced or recurrent ovarian clear cell carcinoma

版权声明：
本网站所有内容来源注明为“梅斯医学”或“MedSci原创”的文字、图片和音视频资料，版权均属于梅斯医学所有。非经授权，任何媒体、网站或个人不得转载，授权转载时须注明来源为“梅斯医学”。其它来源的文章系转载文章，或“梅斯号”自媒体发布的文章，仅系出于传递更多信息之目的，本站仅负责审核内容合规，其内容不代表本站立场，本站不负责内容的准确性和版权。如果存在侵权、或不希望被转载的媒体或个人可与我们联系，我们将立即进行删除处理。
在此留言
评论区 (4)
#插入话题
  1. [GetPortalCommentsPageByObjectIdResponse(id=2010048, encodeId=b09a20100487d, content=<a href='/topic/show?id=6d13948196c' target=_blank style='color:#2F92EE;'>#透明细胞癌#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=77, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=94819, encryptionId=6d13948196c, topicName=透明细胞癌)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=a8f1167, createdName=wmr111, createdTime=Mon Oct 03 17:38:00 CST 2011, time=2011-10-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1978302, encodeId=be3c19e830267, content=<a href='/topic/show?id=3b90e79787f' target=_blank style='color:#2F92EE;'>#细胞癌#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=80, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=77978, encryptionId=3b90e79787f, topicName=细胞癌)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=e457184, createdName=qingting, createdTime=Fri Nov 11 17:38:00 CST 2011, time=2011-11-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1754389, encodeId=db631e543896f, content=<a href='/topic/show?id=340b3688671' target=_blank style='color:#2F92EE;'>#卵巢透明细胞癌#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=74, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=36886, encryptionId=340b3688671, topicName=卵巢透明细胞癌)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=9ec436672078, createdName=huangshifeng, createdTime=Sun Aug 28 01:38:00 CST 2011, time=2011-08-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1626604, encodeId=fa3916266040f, content=<a href='/topic/show?id=2d91449540c' target=_blank style='color:#2F92EE;'>#姑息#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=79, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=44954, encryptionId=2d91449540c, topicName=姑息)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=adea21051784, createdName=经常头晕, createdTime=Fri Aug 05 07:38:00 CST 2011, time=2011-08-05, status=1, ipAttribution=)]
    2011-10-03 wmr111

    #透明细胞癌#

    0

  2. [GetPortalCommentsPageByObjectIdResponse(id=2010048, encodeId=b09a20100487d, content=<a href='/topic/show?id=6d13948196c' target=_blank style='color:#2F92EE;'>#透明细胞癌#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=77, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=94819, encryptionId=6d13948196c, topicName=透明细胞癌)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=a8f1167, createdName=wmr111, createdTime=Mon Oct 03 17:38:00 CST 2011, time=2011-10-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1978302, encodeId=be3c19e830267, content=<a href='/topic/show?id=3b90e79787f' target=_blank style='color:#2F92EE;'>#细胞癌#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=80, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=77978, encryptionId=3b90e79787f, topicName=细胞癌)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=e457184, createdName=qingting, createdTime=Fri Nov 11 17:38:00 CST 2011, time=2011-11-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1754389, encodeId=db631e543896f, content=<a href='/topic/show?id=340b3688671' target=_blank style='color:#2F92EE;'>#卵巢透明细胞癌#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=74, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=36886, encryptionId=340b3688671, topicName=卵巢透明细胞癌)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=9ec436672078, createdName=huangshifeng, createdTime=Sun Aug 28 01:38:00 CST 2011, time=2011-08-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1626604, encodeId=fa3916266040f, content=<a href='/topic/show?id=2d91449540c' target=_blank style='color:#2F92EE;'>#姑息#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=79, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=44954, encryptionId=2d91449540c, topicName=姑息)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=adea21051784, createdName=经常头晕, createdTime=Fri Aug 05 07:38:00 CST 2011, time=2011-08-05, status=1, ipAttribution=)]
    2011-11-11 qingting

    #细胞癌#

    0

  3. [GetPortalCommentsPageByObjectIdResponse(id=2010048, encodeId=b09a20100487d, content=<a href='/topic/show?id=6d13948196c' target=_blank style='color:#2F92EE;'>#透明细胞癌#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=77, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=94819, encryptionId=6d13948196c, topicName=透明细胞癌)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=a8f1167, createdName=wmr111, createdTime=Mon Oct 03 17:38:00 CST 2011, time=2011-10-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1978302, encodeId=be3c19e830267, content=<a href='/topic/show?id=3b90e79787f' target=_blank style='color:#2F92EE;'>#细胞癌#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=80, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=77978, encryptionId=3b90e79787f, topicName=细胞癌)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=e457184, createdName=qingting, createdTime=Fri Nov 11 17:38:00 CST 2011, time=2011-11-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1754389, encodeId=db631e543896f, content=<a href='/topic/show?id=340b3688671' target=_blank style='color:#2F92EE;'>#卵巢透明细胞癌#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=74, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=36886, encryptionId=340b3688671, topicName=卵巢透明细胞癌)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=9ec436672078, createdName=huangshifeng, createdTime=Sun Aug 28 01:38:00 CST 2011, time=2011-08-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1626604, encodeId=fa3916266040f, content=<a href='/topic/show?id=2d91449540c' target=_blank style='color:#2F92EE;'>#姑息#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=79, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=44954, encryptionId=2d91449540c, topicName=姑息)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=adea21051784, createdName=经常头晕, createdTime=Fri Aug 05 07:38:00 CST 2011, time=2011-08-05, status=1, ipAttribution=)]
    2011-08-28 huangshifeng

    #卵巢透明细胞癌#

    0

  4. [GetPortalCommentsPageByObjectIdResponse(id=2010048, encodeId=b09a20100487d, content=<a href='/topic/show?id=6d13948196c' target=_blank style='color:#2F92EE;'>#透明细胞癌#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=77, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=94819, encryptionId=6d13948196c, topicName=透明细胞癌)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=a8f1167, createdName=wmr111, createdTime=Mon Oct 03 17:38:00 CST 2011, time=2011-10-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1978302, encodeId=be3c19e830267, content=<a href='/topic/show?id=3b90e79787f' target=_blank style='color:#2F92EE;'>#细胞癌#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=80, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=77978, encryptionId=3b90e79787f, topicName=细胞癌)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=e457184, createdName=qingting, createdTime=Fri Nov 11 17:38:00 CST 2011, time=2011-11-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1754389, encodeId=db631e543896f, content=<a href='/topic/show?id=340b3688671' target=_blank style='color:#2F92EE;'>#卵巢透明细胞癌#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=74, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=36886, encryptionId=340b3688671, topicName=卵巢透明细胞癌)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=9ec436672078, createdName=huangshifeng, createdTime=Sun Aug 28 01:38:00 CST 2011, time=2011-08-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1626604, encodeId=fa3916266040f, content=<a href='/topic/show?id=2d91449540c' target=_blank style='color:#2F92EE;'>#姑息#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=79, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=44954, encryptionId=2d91449540c, topicName=姑息)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=adea21051784, createdName=经常头晕, createdTime=Fri Aug 05 07:38:00 CST 2011, time=2011-08-05, status=1, ipAttribution=)]
    2011-08-05 经常头晕

    #姑息#

    0

Baidu
map
Baidu
map
Baidu
map